Recombinant VEGF-C (Cys156Ser) improves mesenteric lymphatic drainage and gut immune surveillance in experimental cirrhosis-Reference-Cited by-同舟云学术

Recombinant VEGF-C (Cys156Ser) improves mesenteric lymphatic drainage and gut immune surveillance in experimental cirrhosis

Published:2023-10 Issue:10 Volume:5 Page:100816
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Juneja Pinky,Ruhina Rahman Syed Nazrin,Jakhar Deepika,Mourya Akash Kumar,Tripathi Dinesh M.,Kaur Impreet,Tiwari Vaibhav^ORCID,Rohilla Sumati,Gupta Abhishek,Rawal Preety,Baweja Sukriti,Rastogi Archana,Naidu V.G.M.,Sarin Shiv K.,Banerjee Subham^ORCID,Kaur Savneet^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference42 articles.

1. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Sepanlou;Lancet Gastroenterol Hepatol,2020

2. Burden of liver diseases in the world;Asrani;J Hepatol,2019

3. Corrigendum to ‘Towards a new definition of decompensated cirrhosis’ [J Hepatol 76 (2022) 202–207];D’Amico;J Hepatol,2022

4. The gut–liver axis in liver disease: pathophysiological basis for therapy;Albillos;J Hepatol,2020

5. Leaky gut and gut–liver axis in liver cirrhosis: clinical studies update;Fukui;Gut Liver,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Lymphatic Highway: How Lymphatics Drive Lung Health and Disease;Lung;2024-08-20

2. Prevalence and risk factors of lymphatic dysfunction in cirrhosis patients with refractory ascites: An often unconsidered mechanism;World Journal of Hepatology;2023-10-27